ValueAct sells 2,495,687 shares in Warner Chilcott, trims stake to 4.3%

By Susanna Moon

Chicago, July 25 - Warner Chilcott Ltd. investors led by ValueAct Capital Master Fund LP sold 2,495,687 shares, according to a schedule 13D filing with the Securities and Exchange Commission.

The investors sold shares at prices from $17.00 to $17.61 between July 9 and July 24.

ValueAct is the beneficial owner of 10,704,836 shares, or 4.3%, of the Rockaway, N.J., specialty pharmaceutical company's outstanding shares.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.